Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli.
about
Flow cytometry-based methods for assessing soluble scFv activities and detecting antigens in solution.An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicityAntibody library screens using detergent-solubilized mammalian cell lysates as antigen sources.Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.An evolved Mxe GyrA intein for enhanced production of fusion proteinsCo-expression of foreign proteins tethered to HIV-1 envelope glycoprotein on the cell surface by introducing an intervening second membrane-spanning domain.A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours.A yeast platform for the production of single-chain antibody-green fluorescent protein fusions.Label-free electrochemical detection of an Entamoeba histolytica antigen using cell-free yeast-scFv probes.A compact phage display human scFv library for selection of antibodies to a wide variety of antigens.Different types of aqueous two-phase systems for biomolecule and bioparticle extraction and purification.Cultivation of Pichia pastoris carrying the scFv anti LDL (-) antibody fragment. Effect of preculture carbon source.Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcoma.Production of anti-amoxicillin ScFv antibody and simulation studying its molecular recognition mechanism for penicillins.Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands.E. coli expression of a soluble, active single-chain antibody variable fragment containing a nuclear localization signal.Enhanced production of functional extracellular single chain variable fragment against HIV-1 matrix protein from Escherichia coli by sequential simplex optimization.Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.Biophysical characterization and molecular simulation of electrostatically driven self-association of a single-chain antibody.Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris.
P2860
Q30938677-F75CB16B-C69F-4145-9718-DB8DF7B98479Q33317678-270FF106-67F3-420A-95EC-DC7FF1361A09Q33585960-8417AC5F-1C51-4817-BB34-1F0FF642915BQ33888291-E12D3DC5-35FC-418A-B46F-DF767BCD2A58Q35121107-0551A808-AA2A-49F1-885D-B5C89B287D81Q35164416-5062A9D2-95A2-4716-9C9E-AAE9B358EAF0Q35189765-CE8A7FEE-EA9A-4A4F-8DFB-7449253DF4A5Q35215865-719C3BFB-24EF-48BC-9768-011B5F04A33DQ36588202-CB332DCB-8D83-4A03-AA2E-BF8B7A4FB19CQ37097486-F30C6FB9-C98E-411E-B1C9-DD7ED6AA44D1Q38127392-5C84FBD7-D287-4EDC-8A6E-7527ACD52F5AQ38753196-B82B6484-94A8-4280-8E86-402A72295C21Q38810472-9373B362-89A9-4749-B931-9C3568F85210Q39627934-94ED8E2A-D747-4644-A4C9-AECB809B8563Q40018417-8E818A4B-BD1B-4F44-A28B-E75339A69D5CQ41502781-ECCC4B7F-611F-4E23-8F70-D8D01BFAED14Q42215470-4B005FBF-FF20-4735-BF9A-25737ED90200Q42694844-C83B4401-6FCB-40F1-9547-2818AFC46A5DQ46816575-E67EC023-EE44-40F2-8690-A7F8E2245A0DQ52594673-113F7A01-291E-413F-9886-7AE3FAC36ACDQ54292251-D4C15626-99F0-4238-987C-C5CFC2471733
P2860
Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Production, purification, and ...... astoris, and Escherichia coli.
@ast
Production, purification, and ...... astoris, and Escherichia coli.
@en
type
label
Production, purification, and ...... astoris, and Escherichia coli.
@ast
Production, purification, and ...... astoris, and Escherichia coli.
@en
prefLabel
Production, purification, and ...... astoris, and Escherichia coli.
@ast
Production, purification, and ...... astoris, and Escherichia coli.
@en
P2093
P1476
Production, purification, and ...... astoris, and Escherichia coli.
@en
P2093
Jane Weaver-Feldhaus
Keith D Miller
Michael J Feldhaus
Sean A Gray
P304
P356
10.1016/J.PEP.2005.04.015
P577
2005-08-01T00:00:00Z